Javascript must be enabled to continue!
The Prognostic Importance of Pre and Post Dendritic Cells in Autologous Transplantation for Diffuse Large B Cell Lymphoma.
View through CrossRef
Abstract
Pre and post transplant dendritic cell (DC) levels may correlate with survival, GVHD, and relapse in allogeneic BMT. Whether they have prognostic importance in autologous peripheral blood progenitor cell (PBPC) is unknown. We prospectively collected pre and post dendritic cell levels, including DC1 and DC2 levels in 53 patients with diffuse large B cell lymphoma (DLBCL) to investigate their potential prognostic importance. Pre-transplant analysis of DC1 and DC2 by flow cytometry was obtained 24 hours prior to the initiation of VP-16 (2 gm/m2) or G-CSF (10 mcg/kg/d) (n=4) for PBPC mobilization; post transplant samples were obtained 6 weeks after transplant. 51 of 53 (96%) were sensitive to chemotherapy at the time of transplant; 34% received prior radiation therapy; 15% had an elevated LDH at transplant. 49 of 53 received VP-16 + G-CSF for stem cell mobilization and 4 patients received G-CSF alone. 98% received a preparative regimen of Bu/Cy/VP and one patient received Busulfan alone. In a univariate analysis, higher numbers of pre-transplant DC1 cells and pre-transplant total DC (DC1 + DC2) cells correlated with improved survival, as shown graphically below:
Figure Figure
Patients received a median CD34+ cell dose of 8.7 x 106/kg. DC values did not correlate with CD34+ cell yield. Post-transplant DC1 (p=0.03), DC2 (p=0.035), and post-transplant total DCs (p=0.04) also correlated with improved survival. In all cases, more DCs was associated with a better outcome. In a multivariable model, pre-transplant total DC number (p=0.028), and a normal LDH at the time of transplant (p=0.017) correlated with improved outcome. Median follow up of surviving patients is 15 months. Of 26 patients with pre-transplant total DC numbers greater than 9.10 x 106/mL, 77% of patients are alive, as compared to 56% of patients with pre-transplant total DC numbers less than 9.10 x 106/mL (n= 27)(p=0.022). The high DC group had fewer relapses and fewer late infections. We conclude that higher pre-transplant total DC numbers are associated with improved outcome in ABMT for DLBCL.
Title: The Prognostic Importance of Pre and Post Dendritic Cells in Autologous Transplantation for Diffuse Large B Cell Lymphoma.
Description:
Abstract
Pre and post transplant dendritic cell (DC) levels may correlate with survival, GVHD, and relapse in allogeneic BMT.
Whether they have prognostic importance in autologous peripheral blood progenitor cell (PBPC) is unknown.
We prospectively collected pre and post dendritic cell levels, including DC1 and DC2 levels in 53 patients with diffuse large B cell lymphoma (DLBCL) to investigate their potential prognostic importance.
Pre-transplant analysis of DC1 and DC2 by flow cytometry was obtained 24 hours prior to the initiation of VP-16 (2 gm/m2) or G-CSF (10 mcg/kg/d) (n=4) for PBPC mobilization; post transplant samples were obtained 6 weeks after transplant.
51 of 53 (96%) were sensitive to chemotherapy at the time of transplant; 34% received prior radiation therapy; 15% had an elevated LDH at transplant.
49 of 53 received VP-16 + G-CSF for stem cell mobilization and 4 patients received G-CSF alone.
98% received a preparative regimen of Bu/Cy/VP and one patient received Busulfan alone.
In a univariate analysis, higher numbers of pre-transplant DC1 cells and pre-transplant total DC (DC1 + DC2) cells correlated with improved survival, as shown graphically below:
Figure Figure
Patients received a median CD34+ cell dose of 8.
7 x 106/kg.
DC values did not correlate with CD34+ cell yield.
Post-transplant DC1 (p=0.
03), DC2 (p=0.
035), and post-transplant total DCs (p=0.
04) also correlated with improved survival.
In all cases, more DCs was associated with a better outcome.
In a multivariable model, pre-transplant total DC number (p=0.
028), and a normal LDH at the time of transplant (p=0.
017) correlated with improved outcome.
Median follow up of surviving patients is 15 months.
Of 26 patients with pre-transplant total DC numbers greater than 9.
10 x 106/mL, 77% of patients are alive, as compared to 56% of patients with pre-transplant total DC numbers less than 9.
10 x 106/mL (n= 27)(p=0.
022).
The high DC group had fewer relapses and fewer late infections.
We conclude that higher pre-transplant total DC numbers are associated with improved outcome in ABMT for DLBCL.
Related Results
Primary Thyroid Non-Hodgkin B-Cell Lymphoma: A Case Series
Primary Thyroid Non-Hodgkin B-Cell Lymphoma: A Case Series
Abstract
Introduction
Non-Hodgkin lymphoma (NHL) of the thyroid, a rare malignancy linked to autoimmune disorders, is poorly understood in terms of its pathogenesis and treatment o...
Complex Collision Tumors: A Systematic Review
Complex Collision Tumors: A Systematic Review
Abstract
Introduction: A collision tumor consists of two distinct neoplastic components located within the same organ, separated by stromal tissue, without histological intermixing...
Successful transfection of Lymphoblastoid cell line (Preprint)
Successful transfection of Lymphoblastoid cell line (Preprint)
BACKGROUND
Immortalization is the stage that the cell goes through before full transformation [1]. Human resting B lymphocytes from peripheral blood are eas...
MARS-seq2.0: an experimental and analytical pipeline for indexed sorting combined with single-cell RNA sequencing v1
MARS-seq2.0: an experimental and analytical pipeline for indexed sorting combined with single-cell RNA sequencing v1
Human tissues comprise trillions of cells that populate a complex space of molecular phenotypes and functions and that vary in abundance by 4–9 orders of magnitude. Relying solely ...
Generation of Human Anti-Leukemia CTL Vaccine Utilizing Dendritic Cell Hybrids.
Generation of Human Anti-Leukemia CTL Vaccine Utilizing Dendritic Cell Hybrids.
Abstract
The therapeutic options for patients with hematological malignancies that relapse after autologous or allogeneic hematopoietic stem cell transplantation (SC...
The Analysis of HIV-Associated Lymphoma in Japan
The Analysis of HIV-Associated Lymphoma in Japan
Abstract
Background.
The recent advance of antiretroviral therapy decreased the morbidity of opportunistic infections. However, the incidence of HIV-a...
Beneficios de la quimioterapia adyuvante en los resultados de supervivencia del cáncer de mama triple negativo pT1N0M0
Beneficios de la quimioterapia adyuvante en los resultados de supervivencia del cáncer de mama triple negativo pT1N0M0
Introduction Collaborative health research has proven to be an effective approach to addressing regional and international challenges in the diagnosis, treatment, and management o...
Interdigitating Dendritic Cell Sarcoma and Indeterminate Dendritic Cell Tumor: Patient Characteristics, Prognostic Factors, and Survival Outcomes for Rare Dendritic Cell Neoplasms
Interdigitating Dendritic Cell Sarcoma and Indeterminate Dendritic Cell Tumor: Patient Characteristics, Prognostic Factors, and Survival Outcomes for Rare Dendritic Cell Neoplasms
Background
Dendritic cells are nonlymphoid, nonphagocytic, antigen-presenting cells present in lymphoid and nonlymphoid tissue. There are 4 types of dendritic cells:...

